AHL
TAK icon

Abel Hall LLC’s Takeda Pharmaceutical TAK Stock Holding History

Abel Hall LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Buy
40,603
+6,504
+19% +$108K 0.11% 165
2026
Q1 		$632K Buy
34,099
+781
+2% +$13.7K 0.13% 136
2025
Q4 		$519K Buy
+33,318
New +$476K 0.12% 165

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Abel Hall LLC's TAK Position: Q2 2026 in Review

Abel Hall LLC increased its Takeda Pharmaceutical (TAK) stake by 19% in Q2 2026, buying an estimated $108K and bringing the position to 40,603 shares worth $651K. The position accounts for 0.11% of the portfolio, ranked #165.

Abel Hall LLC first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Abel Hall LLC held 40,603 shares of Takeda Pharmaceutical worth $651K as of Q2 2026.
  • Abel Hall LLC bought 6,504 Takeda Pharmaceutical shares in Q2 2026, an estimated $108K.
  • Takeda Pharmaceutical made up 0.11% of Abel Hall LLC's portfolio in Q2 2026, its #165 holding.
  • Abel Hall LLC first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.